Drug Target Review – Issue 3 2018
Posted: 3 September 2018 | Drug Target Review | No comments yet
In this issue: pharmacological targeting of mitochondrial dysfunction in Parkinson’s disease, the evolving role of three dimensional in-vitro cell culture techniques in drug discovery, and NGS: hunting mysterious ‘Dark Matter Genome’ towards rewriting the rules of genetic diseases.
In this issue:
- FOREWORD: The changing face in drug discovery
Pushpanathan Muthuirulan, Harvard University - ASSAYS: Applications of high content screening in autophagy
Saba Ezazi Erdi, Ole Pless and Sheraz Gul Fraunhofer-IME - UPSTREAM BIOPROCESSING: Upstream cell culture processes for the production of therapeutic proteins
Jonathan P. Wels Principal Scientist, Centre for Process Innovation, National Biologics Manufacturing Centre, Darlington, UK - SYNTHETIC BIOLOGY: Synthetic biology in drug discovery
Dr Tim Brears, Chief Executive Officer, Evonetix - ANTIBODIES: Aggregate formation for monoclonal antibodies
Tony Edge, Agilent Technologies, UK - PARKINSON’S: Pharmacological targeting of mitochondrial dysfunction in Parkinson’s disease: approaches and perspectives
Iryna Mankovska, Olga Gonchar, Kateryna Rozova, Larysa Bratus and Iryna Karaban - FLOW CYTOMETRY: How recent advances in flow cytometry can aid drug discovery
Rachael Walker, Head of Flow Cytometry at Babraham Institute, Cambridge, UK and Derek Davies, Science Technology Platform Head, The Francis Crick Institute - METABOLICS: Metabolomics in drug and biomarker discovery
Giuseppe Astarita, Senior Scientist, Denali Therapeutics - NEXT-GENERATION SEQUENCING: Hunting mysterious ‘Dark Matter Genome’ towards rewriting the rules of human genetic diseases
Pushpanathan Muthuirulan, Harvard University, Cambridge
Issue 3 2018 of Drug Target Review is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Antibodies, Assays, Flow Cytometry, Metabolomics, Next-Generation Sequencing (NGS)
